CVS Health beats by $0.08, beats on revs; guides FY19 EPS below consensus
- Reports Q4 (Dec) earnings of $2.14 per share, excluding non-recurring items, $0.08 better than the S&P Capital IQ Consensus of $2.06; revenues rose 12.5% year/year to $54.42 bln vs the $53.78 bln S&P Capital IQ Consensus.
- Co issues downside guidance for FY19, sees EPS of $6.68-6.88, excluding non-recurring items, vs. $7.34 S&P Capital IQ Consensus. The Company's full year 2019 consolidated GAAP operating income is projected to be in the range of $11.7 billion to $12.1 billion while adjusted operating income is projected to be in the range of $14.8 billion to $15.2 billion.
No comments:
Post a Comment